ESA risks in cancer patients under review.(News)(erythropoiesis-stimulating agents)(Brief article)
Publication: Internal Medicine News
Publication Date: 15-JAN-08
Author: Mechcatie, Elizabeth
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
More evidence associating erythropoiesis-stimulating agents with increased tumor growth and mortality in patients with cancer is being reviewed at the Food and Drug Administration and could result in additional action by the agency.
The new data are from two studies, according to an FDA statement. In one study of...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
